Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly
- PMID: 2217688
Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly
Abstract
The pathogenesis of the hypertension associated with Cushing's syndrome and with acromegaly is poorly understood. We have investigated the possible roles of sodium retention, activation of the renin-angiotensin system and increased sympathetic nervous system activity in untreated patients. In 11 patients with Cushing's disease, seven of whom were hypertensive, total exchangeable sodium was normal despite increased levels of the mineralocorticoid hormones, 11-deoxy-corticosterone and corticosterone. The renin-angiotensin system was also normal. Cardiac sensitivity to the beta-receptor agonist isoprenaline was increased, but this was not due to an increase in beta-adrenoceptor density. Hypertension in Cushing's disease is neither sodium-dependent nor angiotensin II-mediated, but increased cardiac sensitivity to catecholamines, by increasing cardiac output, may contribute to the pathogenesis of hypertension. In nine patients with acromegaly (three of whom were hypertensive) total exchangeable sodium was elevated. Although no correlation between blood pressure and exchangeable sodium was found, hypertension in acromegaly is probably sodium dependent. No evidence was found for a pathogenetic role for either the renin-angiotensin-aldosterone or the sympathetic nervous system.
Similar articles
-
[Hypertension and Cushing's disease].Ann Med Interne (Paris). 1983;134(3):203-8. Ann Med Interne (Paris). 1983. PMID: 6625411 French.
-
[The renin-angiotensin-aldosterone (RAA) system in endocrine diseases].Wiad Lek. 1990 Jul 1;43(13):679-84. Wiad Lek. 1990. PMID: 2256331 Review. Polish.
-
Hypertension in Cushing's syndrome.Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):467-82. doi: 10.1016/j.beem.2006.07.006. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 16980206 Review.
-
Body composition, blood pressure and the renin-angiotensin system in acromegaly before and after treatment.J Hypertens Suppl. 1985 Dec;3(3):S413-5. J Hypertens Suppl. 1985. PMID: 2856753
-
Hypertension in Cushing's syndrome: from pathogenesis to treatment.Neuroendocrinology. 2010;92 Suppl 1:44-9. doi: 10.1159/000314315. Epub 2010 Sep 10. Neuroendocrinology. 2010. PMID: 20829617 Review.
Cited by
-
Unique Gene Expression Signature in Periadrenal Adipose Tissue Identifies a High Blood Pressure Group in Patients With Cushing Syndrome.Hypertension. 2023 Nov;80(11):2333-2344. doi: 10.1161/HYPERTENSIONAHA.123.21185. Epub 2023 Aug 30. Hypertension. 2023. PMID: 37646167 Free PMC article.
-
Cardiovascular consequences of cortisol excess.Vasc Health Risk Manag. 2005;1(4):291-9. doi: 10.2147/vhrm.2005.1.4.291. Vasc Health Risk Manag. 2005. PMID: 17315601 Free PMC article. Review.
-
Cushing's Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography.Front Endocrinol (Lausanne). 2021 Oct 1;12:751743. doi: 10.3389/fendo.2021.751743. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34659130 Free PMC article.
-
Pathogenesis and prevalence of hypertension in acromegaly.Pituitary. 2001 Sep;4(4):239-49. doi: 10.1023/a:1020798430884. Pituitary. 2001. PMID: 12501974 Review.
-
Cardiovascular risk and mortality in patients with active and treated hypercortisolism.Gland Surg. 2020 Feb;9(1):43-58. doi: 10.21037/gs.2019.11.03. Gland Surg. 2020. PMID: 32206598 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical